Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2018 08:00 ET | Source: Aphios

Aphios Is Developing Pathogen Inactivation Technology For Human Plasma Units

WOBURN, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung...
September 17, 2018 08:00 ET | Source: Aphios

Aphios Pharma LLC Announces Reg. CF Private Placement Offering

WOBURN, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aphios® Pharma LLC is pleased to announce the launch of a private placement offering in accordance with Regulation Crowdfunding (Reg. CF) adopted...
June 19, 2018 08:00 ET | Source: Aphios

Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation

WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United...
June 05, 2018 08:00 ET | Source: Aphios

Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology

WOBURN, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it has been granted United States Patent No. 9,981,238 entitled “Apparatus and Methods for Making Nanosomes...
December 08, 2017 08:00 ET | Source: Aphios

Aphios Pharma Raising Equity Capital to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction

WOBURN, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aphios® Pharma today announced plans to raise equity capital from investors to develop an FDA-approved, cannabis-based drug for treating opioid...
December 01, 2017 08:00 ET | Source: Aphios

Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure

WOBURN, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it is developing a platform for the effective targeted delivery of siRNA-based Therapeutics with funding from...
February 22, 2017 08:00 ET | Source: Aphios

Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction, Epilepsy and Multiple Sclerosis

WOBURN, Mass., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Aphios® Corporation today announced that it is spinning-off Aphios® Pharma to develop FDA-approved, cannabis-based drugs for treating highly unmet...